Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Report No.: 24040
Congress could pass a law to allow the drugs to be covered
Emerging research suggests these medications may influence food preferences and cravings
They found that intestinal flora may mediate the release of the intestinal hormone GLP-1 through the short-chain fatty acid (SCFA)-GPCR pathway, thereby increasing satiety and slowing gastric emptying, ultimately reducing obesity
Government-led health campaigns, rising insurance coverage, and local production of cost-effective GLP-1 drugs are propelling growth, especially in metro and tier-2 cities
US$ 23.63
US$ 20.85
US$ 28.25
